AUSTIN, Texas, Aug. 30, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) announced today that management will present at two upcoming investment conferences, the Morgan Stanley Global Healthcare Conference and the UBS Global Life Sciences Conference, both scheduled to take place in New York City.
Patrick J. Balthrop, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on September 13, 2011 at 1 p.m. Eastern time, and at the UBS Global Life Sciences Conference on September 19, 2011 at 10 a.m. Eastern time.
The presentations will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.
Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP technology can be obtained at www.luminexcorp.com. Contacts:
Harriss T. CurrieVice President, Finance and Chief Financial Officer512-219-8020Matthew ScaloSr. Director of Investor Relations512email@example.com
|SOURCE Luminex Corporation|
Copyright©2010 PR Newswire.
All rights reserved